Vertex Pharmaceuticals stock surges 6% on kidney drug trial win

Investing.com Gold reports: Vertex Pharmaceuticals stock surges 6% on kidney drug trial win. This is a premium/paywalled source, so the brief is based on headline and available metadata only.